MamasM., DunnW.B., NeysesL., GoodacreR.The role of metabolites and metabolomics in clinically applicable biomarkers of disease.Arch Toxicol2011; 85(1): 5–17.
2.
KellD.B., BrownM., DaveyH.M., DunnW.B., SpasicI., OliverS.G.Metabolic footprinting and systems biology: the medium is the message.Nature reviews Microbiology2005; 3(7): 557–65.
3.
DunnW.B., SummersA., BrownM., GoodacreR., LambieM., JohnsonT.Proof-of-principle study to detect metabolic changes in peritoneal dialysis effluent in patients who develop encapsulating peritoneal sclerosis.Nephrol Dial Transplant2012; 27(6): 2502–10.
4.
KasperD.C., HermanJ., De JesusV.R., MechtlerT.P., MetzT.F., ShushanB.The application of multiplexed, multi-dimensional ultra-high-performance liquid chromatography/tandem mass spectrometry to the high-throughput screening of lysosomal storage disorders in newborn dried bloodspots.Rapid Commun Mass Spectrom2010; 24(7): 986–94.
5.
RheeE.P., ThadhaniR.New insights into uremia-induced alterations in metabolic pathways.Curr Opin Nephrol Hypertens2011; 20(6): 593–8.
6.
SchefoldJ.C., ZedenJ.P., FotopoulouC., von HaehlingS., PschowskiR., HasperD.Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.Nephrol Dial Transplant2009; 24(6): 1901–8.
7.
PawlakK., MysliwiecM., PawlakD.Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients.Thromb Res2010; 125(2): e40–5.
8.
KratochwillK., BoehmM., HerzogR., LichtenauerA.M., SalzerE., LechnerM.Alanyl-glutamine dipeptide restores the cytoprotective stress proteome of mesothelial cells exposed to peritoneal dialysis fluids.Nephrol Dial Transplant2012; 27(3): 937–46.
